Literature DB >> 27861212

The Interobserver and Intraobserver Reliability of the Sanders Classification Versus the Risser Stage.

Shaleen Vira1, Qasim Husain, Cyrus Jalai, Justin Paul, Gregory W Poorman, Caroline Poorman, Richard S Yoon, Christopher Looze, Baron Lonner, Peter G Passias.   

Abstract

BACKGROUND: Estimation of skeletal maturity, classically performed using Risser sign, plays a crucial role in the treatment of AIS. Recent data, however, has shown the simplified Tanner-Whitehouse (Sanders) classification, based on an anteriorposterior (AP) hand radiographs, to correlate more closely to the rapid growth phase and thus curve progression. This study evaluated the interobserver and intraobserver reliability of the Sanders and Risser classifications among clinicians at different levels of training.
METHODS: Twenty AP scoliosis radiographs and 20 AP hand radiographs were randomized and distributed to 11 graders. The graders consisted of 3 orthopaedic residents, 3 spine fellows, 3 spine surgeons, and 1 radiologist. The graders were then asked to classify the radiographs according to the Sanders and Risser classifications. There were 3 rounds of grading, each done 3 weeks apart. The overall κ coefficient was then calculated for each system to evaluate the interobserver and intraobserver reliability.
RESULTS: For all graders the average κ coefficient for the interobserver and intraobserver reliability of the Sanders classification was 0.54 and 0.62, respectively, and 0.46 and 0.49 for the Risser classification. With respect to spine attendings alone, the average κ coefficient for the interobserver and intraobserver reliability of Sanders classification was 0.72 and 0.77, respectively, and 0.46 and 0.67 for the Risser classification.
CONCLUSIONS: Our study demonstrated that the Sanders classification had moderate reliability with respect to physicians at various levels of training and had good reliability with respect to attending spine surgeons. Interestingly, the Risser staging was found to have less interobserver and intraobserver reliability overall. The Sanders classification is a reliable and reproducible system and should be in the armamentarium of surgeons who treat adolescent idiopathic scoliosis. LEVEL OF EVIDENCE: Level III.

Entities:  

Mesh:

Year:  2017        PMID: 27861212     DOI: 10.1097/BPO.0000000000000891

Source DB:  PubMed          Journal:  J Pediatr Orthop        ISSN: 0271-6798            Impact factor:   2.324


  4 in total

1.  Bracing in Adolescent Idiopathic Scoliosis Trial (BrAIST): Development and Validation of a Prognostic Model in Untreated Adolescent Idiopathic Scoliosis Using the Simplified Skeletal Maturity System.

Authors:  Lori A Dolan; Stuart L Weinstein; Mark F Abel; Patrick P Bosch; Matthew B Dobbs; Tyler O Farber; Matthew F Halsey; M Timothy Hresko; Walter F Krengel; Charles T Mehlman; James O Sanders; Richard M Schwend; Suken A Shah; Kushagra Verma
Journal:  Spine Deform       Date:  2019-11

2.  Sequential spine-hand radiography for assessing skeletal maturity with low radiation EOS imaging system for bracing treatment recommendation in adolescent idiopathic scoliosis: a feasibility and validity study.

Authors:  L C M Lau; A L H Hung; W W Chau; Z Hu; A Kumar; T P Lam; W C W Chu; J C Y Cheng
Journal:  J Child Orthop       Date:  2019-08-01       Impact factor: 1.548

3.  The Uniform Pattern of Growth and Skeletal Maturation during the Human Adolescent Growth Spurt.

Authors:  James O Sanders; Xing Qiu; Xiang Lu; Dana L Duren; Raymond W Liu; Debbie Dang; Mariano E Menendez; Sarah D Hans; David R Weber; Daniel R Cooperman
Journal:  Sci Rep       Date:  2017-12-01       Impact factor: 4.379

4.  Humeral Head Ossification Predicts Peak Height Velocity Timing and Percentage of Growth Remaining in Children.

Authors:  Don T Li; Jonathan J Cui; Stephen DeVries; Allen D Nicholson; Eric Li; Logan Petit; Joseph B Kahan; James O Sanders; Raymond W Liu; Daniel R Cooperman; Brian G Smith
Journal:  J Pediatr Orthop       Date:  2018-10       Impact factor: 2.324

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.